Figure 2 | Hypertension Research

Figure 2

From: Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy

Figure 2

Plasma visfatin/NAMPT levels in healthy pregnant (N=107), patients with gestational hypertension (N=105) and preeclampsia (N=90) grouped according to the genotypes for the NAMPT polymorphisms T>C (rs1319501, a) and A>G (rs3801266, b), and the haplotypes formed by them (c). The bars show the mean±s.e.m. *P<0.05 vs. the gestational hypertension subjects with the AA genotype (b), or vs. gestational hypertension subjects with TA or CA haplotypes (c).

Back to article page